Investors & Media Company Overview UNITY Biotechnology is developing therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating medicines that target cellular senescence and aging-related biology in ophthalmologic and neurologic diseases, while leveraging partnerships in growth areas with high unmet need. Stock Information Data Provided by Refinitiv. Minimum 15 minutes delayed. Latest Presentation Download News Releases February 26, 2021 UNITY Biotechnology to Participate in Upcoming March Investor Conferences February 24, 2021 UNITY Biotechnology Reports Granting of New Employment Inducement Awards
